Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

531.00p
   
  • Change Today:
    186.00p
  • 52 Week High: 706.00p
  • 52 Week Low: 130.00p
  • Currency: UK Pounds
  • Shares Issued: 4.73m
  • Volume: 339,505
  • Market Cap: £25.10m
  • RiskGrade: 340

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Alexis M. Sandler 187,727 £996,830
Vladislav Sandler Ph.D. 103,862 £551,507
Peter Redmond 13,991 £74,292

Major Shareholders

Notifier** Holding Value*
Alexis Sandler 187,727 £996,830
Dr Vladislav Sandler 103,862 £551,507
Optiva Securities Limited 70,329 £373,447
Flascherberg Capital Anstalt 69,991 £371,652
Craig Auringer 59,593 £316,439
HSBC Client Holdings Nominee (UK) Limited 45,160 £239,800
Ron Valk 42,828 £227,417
Samantha Bauer 42,706 £226,769
Plum Capital 29,232 £155,222
43 North LLC 28,429 £150,958
Abdelatif LACHAB 6,500 £34,515
Wayne Gibson 6,500 £34,515

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 531.00p
Change Today 186.00p
% Change 53.91 %
52 Week High 706.00p
52 Week Low 130.00p
Volume 339,505
Shares Issued 4.73m
Market Cap £25.10m
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47% below the market average47% below the market average47% below the market average47% below the market average47% below the market average
56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average
Price Trend
91.8% below the market average91.8% below the market average91.8% below the market average91.8% below the market average91.8% below the market average
90.91% below the sector average90.91% below the sector average90.91% below the sector average90.91% below the sector average90.91% below the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 29-Aug-2025

Time Volume / Share Price
11:56 11 @ 538.00p
11:56 90 @ 538.00p
11:55 48 @ 522.00p
11:55 20 @ 540.00p
11:55 2 @ 540.00p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page